Joan Bartlett

1.7k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Joan Bartlett is a scholar working on Epidemiology, Microbiology and Parasitology. According to data from OpenAlex, Joan Bartlett has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 7 papers in Microbiology and 6 papers in Parasitology. Recurrent topics in Joan Bartlett's work include Herpesvirus Infections and Treatments (11 papers), Bacterial Infections and Vaccines (7 papers) and Influenza Virus Research Studies (5 papers). Joan Bartlett is often cited by papers focused on Herpesvirus Infections and Treatments (11 papers), Bacterial Infections and Vaccines (7 papers) and Influenza Virus Research Studies (5 papers). Joan Bartlett collaborates with scholars based in United States. Joan Bartlett's co-authors include Bruce Fireman, Nicola P. Klein, Roger Baxter, Ali Rowhani‐Rahbar, Edwin Lewis, Laurie Aukes, John Hansen, Patricia Saddier, Morgan A. Marks and Ned Lewis and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PEDIATRICS.

In The Last Decade

Joan Bartlett

19 papers receiving 1.1k citations

Hit Papers

Waning Protection after Fifth Dose of Acellular Pertussis... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Bartlett United States 13 946 757 257 231 101 21 1.1k
Nicoline van der Maas Netherlands 19 716 0.8× 467 0.6× 328 1.3× 250 1.1× 66 0.7× 65 1.0k
Jane Gidudu United States 13 252 0.3× 97 0.1× 197 0.8× 233 1.0× 62 0.6× 30 570
Gaby Smits Netherlands 18 522 0.6× 76 0.1× 269 1.0× 279 1.2× 17 0.2× 38 860
Kathy Kudish United States 10 482 0.5× 454 0.6× 177 0.7× 113 0.5× 25 0.2× 16 572
Jorge Quian Uruguay 6 362 0.4× 245 0.3× 137 0.5× 80 0.3× 12 0.1× 28 428
Steve Black United States 14 313 0.3× 78 0.1× 129 0.5× 216 0.9× 15 0.1× 27 749
Claudia Miller United States 8 534 0.6× 371 0.5× 200 0.8× 145 0.6× 16 0.2× 13 667
Jennifer B. Rosen United States 18 839 0.9× 195 0.3× 386 1.5× 247 1.1× 11 0.1× 41 1.1k
María Garcés‐Sánchez Spain 14 625 0.7× 222 0.3× 140 0.5× 179 0.8× 14 0.1× 66 756
Stéphane Thomas France 13 442 0.5× 128 0.2× 98 0.4× 99 0.4× 6 0.1× 35 547

Countries citing papers authored by Joan Bartlett

Since Specialization
Citations

This map shows the geographic impact of Joan Bartlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Bartlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Bartlett more than expected).

Fields of papers citing papers by Joan Bartlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Bartlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Bartlett. The network helps show where Joan Bartlett may publish in the future.

Co-authorship network of co-authors of Joan Bartlett

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Bartlett. A scholar is included among the top collaborators of Joan Bartlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Bartlett. Joan Bartlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zerbo, Ousseny, Joan Bartlett, Bruce Fireman, et al.. (2025). P-41. Effectiveness of recombinant zoster vaccine against postherpetic neuralgia in a real-world setting. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Zerbo, Ousseny, Joan Bartlett, Kristin Goddard, et al.. (2025). Recombinant Zoster Vaccination and Risk of Postherpetic Neuralgia or Zoster Ophthalmicus. JAMA Network Open. 8(6). e2514615–e2514615.
3.
Zerbo, Ousseny, Joan Bartlett, Bruce Fireman, et al.. (2024). Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Annals of Internal Medicine. 177(2). 189–195. 24 indexed citations
4.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2023). Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ. 383. e076321–e076321. 18 indexed citations
5.
Zerbo, Ousseny, Joan Bartlett, Kristin Goddard, et al.. (2019). Acellular Pertussis Vaccine Effectiveness Over Time. PEDIATRICS. 144(1). e20183466–e20183466. 36 indexed citations
6.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2019). Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine. 37(36). 5422–5427. 26 indexed citations
7.
Marks, Morgan A., Joan Bartlett, Bruce Fireman, et al.. (2018). 2481. Impact of Sex and Race/Ethnicity on the Effectiveness of Live Zoster Vaccine. Open Forum Infectious Diseases. 5(suppl_1). S743–S744. 1 indexed citations
8.
Baxter, Roger, Joan Bartlett, Bruce Fireman, Edwin Lewis, & Nicola P. Klein. (2017). Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. PEDIATRICS. 139(5). 176 indexed citations
9.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, et al.. (2017). Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine. 35(26). 3395–3400. 26 indexed citations
10.
Aukes, Laurie, Joan Bartlett, Bruce Fireman, et al.. (2017). Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO). Open Forum Infectious Diseases. 4(suppl_1). S413–S413. 1 indexed citations
11.
Baxter, Roger, Joan Bartlett, Bruce Fireman, Edwin Lewis, & Nicola P. Klein. (2017). Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. Obstetrical & Gynecological Survey. 72(11). 629–630. 1 indexed citations
12.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, & Roger Baxter. (2016). Waning Tdap Effectiveness in Adolescents. PEDIATRICS. 137(3). e20153326–e20153326. 97 indexed citations
13.
Baxter, Roger, Joan Bartlett, Bruce Fireman, et al.. (2016). Effectiveness of Live Zoster Vaccine in Preventing Postherpetic Neuralgia (PHN). Open Forum Infectious Diseases. 3(suppl_1). 5 indexed citations
14.
Baxter, Roger, Joan Bartlett, Bruce Fireman, et al.. (2015). Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
15.
Klein, Nicola P., Joan Bartlett, Bruce Fireman, Ali Rowhani‐Rahbar, & Roger Baxter. (2013). Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers. PEDIATRICS. 131(6). e1716–e1722. 145 indexed citations
16.
Jacoby, Enrique, et al.. (2013). Uso doméstico de sales de rehidratación oral y letalidad por cólera durante la epidemia de 1991 en la ciudad de Piura.. Revista Médica Herediana. 5(2). 1 indexed citations
17.
Baxter, Roger, Trung N. Tran, John Hansen, et al.. (2012). Safety of Zostavax™—A cohort study in a managed care organization. Vaccine. 30(47). 6636–6641. 29 indexed citations
18.
Klein, Nicola P., Joan Bartlett, Ali Rowhani‐Rahbar, Bruce Fireman, & Roger Baxter. (2012). Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children. New England Journal of Medicine. 367(11). 1012–1019. 408 indexed citations breakdown →
19.
Baxter, Roger, Seth Toback, Frangiscos Sifakis, et al.. (2012). A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age. Vaccine. 30(20). 3053–3060. 23 indexed citations
20.
Baxter, Roger, Seth Toback, Frangiscos Sifakis, et al.. (2012). A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age. Vaccine. 30(19). 2989–2998. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026